CHRNB1 variants are known to cause congenital myasthenic syndrome (CMS2A; OMIM #616313, AD), characterized by abnormal fatigability and transient/permanent weakness of extraocular, facial, bulbar, truncal, respiratory, or limb muscles. Here, CHRNB1 is linked to congenital myasthenic syndrome.